▲ The above picture is not related to the content of the article.
A candidate material for a corona treatment that can catch mutations has been developed for the first time in Korea.
The research was conducted by a research team at Yonsei University Medical School with the support of the Ministry of Health and Welfare, the Health Industry Promotion Agency and the National Research Foundation of the Ministry of Science and Technology and Information and Communication.
Although it is at an early stage, it is drawing attention from the academic community as it is expected to have a strong antiviral effect and prevent serious complications.
Researchers have captured that when a coronavirus enters the body, human cells react together.
When a substance that inhibits human cell responses was administered, the cells did not respond even when the virus approached.
Not only the Wuhan virus, but also the alpha, beta, delta, and omicron mutants showed the same effect.
Existing treatments have a weakness in mutation, but this can be overcome.
Domestic candidates are also expected to prevent serious complications of the coronavirus, such as blood clots.
The research team is conducting animal tests, and it is expected that actual clinical trials will be carried out within one year.
More detailed news will be delivered on the 8 o'clock news.